Log in to save to my catalogue

Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model

Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ce72786cd364a1790e07c62806231bf

Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model

About this item

Full title

Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model

Publisher

England: John Wiley & Sons, Inc

Journal title

Clinical and translational allergy, 2022-03, Vol.12 (3), p.e12128-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Evidence regarding the effectiveness of allergen immunotherapy (AIT) on allergic rhinitis has been provided mostly by randomised controlled trials, with little data from real‐life studies.
Objective
To compare the reported control of allergic rhinitis symptoms in three groups of users of the MASK‐air® app: those receiving sublin...

Alternative Titles

Full title

Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ce72786cd364a1790e07c62806231bf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ce72786cd364a1790e07c62806231bf

Other Identifiers

ISSN

2045-7022

E-ISSN

2045-7022

DOI

10.1002/clt2.12128

How to access this item